Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease

Area of Science:

• Hematology
• Immunology
• Pediatric Oncology

Background:

• Limited data exists on factors influencing nonrelapse mortality (NRM) and overall survival in pediatric patients with chronic graft-versus-host disease (cGVHD).
• Understanding these factors is vital for improving outcomes in this vulnerable population.

Purpose of the Study:

• To identify risk factors for NRM and survival in pediatric allograft recipients diagnosed with cGVHD.
• To provide data for risk stratification, clinical trial design, and patient counseling.

Main Methods:

• Multivariate analysis of data from 1117 pediatric subjects with leukemia or myelodysplastic syndrome.
• Analysis included patients transplanted from related donors, unrelated donors (URD), or unrelated cord blood (1995-2004).
• Identified risk factors for NRM and survival post-cGVHD diagnosis.

Main Results:

• Four variables linked to higher NRM: HLA partially matched/mismatched URD, peripheral blood stem cell graft, low Karnofsky/Lansky score (<80), and low platelet count (<100 × 10^9/L).
• Worse survival associated with: age >10 years, HLA partially matched/mismatched URD, advanced disease, low Karnofsky/Lansky score, and low platelet count.
• Cumulative incidence of discontinuing immunosuppression at 1, 3, and 5 years was 22%, 34%, and 37% respectively.

Conclusions:

• This study identifies key variables affecting outcomes in pediatric cGVHD patients.
• These findings can aid in risk stratification, clinical trial development, and family counseling.
• Further research can refine management strategies for pediatric cGVHD.